Literature DB >> 12734043

Nonsurgical approaches to esophageal malignancy.

Darius Sorbi1, David E Fleischer.   

Abstract

Esophageal cancer remains one of the leading causes of cancer death worldwide. Patients generally present with progressive dysphagia, malnutrition, and weight loss. The diagnosis commonly involves radiologic studies and conventional esophagogastroduodenoscopy. Advances in endoscopic evaluation have allowed early detection of premalignant and malignant lesions. These techniques include chromoscopy, which can be performed in conjunction with high-resolution/magnification endoscopy, and fluorescent endoscopy. Such techniques as endoscopic ultrasound with dedicated echoendoscopes or high-frequency probes, positron emission tomography, optical coherence tomography, endoscopic magnetic resonance imaging, and tactile sensing may complement conventional imaging by CT to enhance staging accuracy. Because the majority of patients present with incurable disease at the time of diagnosis, nonsurgical approaches to their management have evolved. These include endoscopic mucosal resection, stenting, tumor ablation, and palliative chemoradiotherapy. The ablative techniques include argon plasma coagulator therapy, laser, and photodynamic therapy. For patients with early malignancies of the esophagus who are not surgical candidates, such techniques may be used with curative intent.

Entities:  

Mesh:

Year:  2003        PMID: 12734043     DOI: 10.1007/s11894-003-0022-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  46 in total

1.  Endoscopic Nd:YAG laser therapy combined with local chemotherapy of superficial carcinomas of the oesophagus and gastric cardia.

Authors:  Y Wang; C Zhou; J Jia; T Huang
Journal:  Lasers Med Sci       Date:  2001       Impact factor: 3.161

2.  Optical coherence tomography of the esophagus and proximal stomach in health and disease.

Authors:  G Zuccaro; N Gladkova; J Vargo; F Feldchtein; E Zagaynova; D Conwell; G Falk; J Goldblum; J Dumot; J Ponsky; G Gelikonov; B Davros; E Donchenko; J Richter
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

3.  Endoscopic fluorescence spectroscopy in the upper GI tract for the detection of GI cancer: initial experience.

Authors:  B Mayinger; P Horner; M Jordan; C Gerlach; T Horbach; W Hohenberger; E G Hahn
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

Review 4.  Endoscopic palliation of malignant dysphagia.

Authors:  D G Adler; T H Baron
Journal:  Mayo Clin Proc       Date:  2001-07       Impact factor: 7.616

5.  Light-induced autofluorescence spectroscopy for the endoscopic detection of esophageal cancer.

Authors:  B Mayinger; P Horner; M Jordan; C Gerlach; T Horbach; W Hohenberger; E G Hahn
Journal:  Gastrointest Endosc       Date:  2001-08       Impact factor: 9.427

6.  The ultrasonic tactile sensor: in vivo clinical application for evaluation of depth of invasion in esophageal squamous cell carcinomas.

Authors:  T Yoshida; H Inoue; T Kawano; K Takeshita; T Iwai
Journal:  Endoscopy       Date:  1999-08       Impact factor: 10.093

Review 7.  Carcinoma of esophagus: radiologic diagnosis and staging.

Authors:  Basak Kumbasar
Journal:  Eur J Radiol       Date:  2002-06       Impact factor: 3.528

8.  Cytologic screening for esophageal cancer in a high-risk population in Anyang County, China.

Authors:  Huihua Yang; Aasmund Berner; Qiang Mei; Karl-Erik Giercksky; Trond Warloe; Guanrui Yang; Jianguo Cui; Zhenhe Suo; Sanshen Zhang; Jahn M Nesland
Journal:  Acta Cytol       Date:  2002 May-Jun       Impact factor: 2.319

9.  Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up of esophageal lesions.

Authors:  B Mayinger; S Neidhardt; H Reh; P Martus; E G Hahn
Journal:  Gastrointest Endosc       Date:  2001-11       Impact factor: 9.427

10.  Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma.

Authors:  Vinay K Gupta; James O Park; Nora T Jaskowiak; Helena J Mauceri; Saraswathy Seetharam; Ralph R Weichselbaum; Mitchell C Posner
Journal:  Ann Surg Oncol       Date:  2002-06       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.